Article Details

On March, 20 Analysts See $0.11 EPS for BioSyent Inc. (RX)

Retrieved on: 2019-03-04 01:50:58

Tags for this article:

Click the tags to see associated articles and topics

On March, 20 Analysts See $0.11 EPS for BioSyent Inc. (RX). View article details on HISWAI:

Excerpt

<div>Wall Street forecasts 22.22 % EPS growth as of March, 20. ... Inc (TSE:ACB) CCO Cam Battley on Spin-out and <b>Canopy Growth Corp</b> – Constellation ...</div>

Article found on:

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up